Activated Charcoal clinical trials
Activated Charcoal is named as an intervention in 3 current clinical trials in our Canada, UK, USA, India, China, Germany, France, Spain, Italy, Belgium, Denmark, Poland, Switzerland, Austria, Czechia, Portugal, Turkey, Brazil, Mexico, Japan, South Korea, Taiwan, Singapore, Israel and Egypt registers. 2 are recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is Sanofi (1). The most-studied condition is Multiple Sclerosis.
What health systems spend on Activated Charcoal
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Activated Charcoal works
All drug targets →- Crohn diseasePhase 3
- Acute kidney injuryPhase 3
- Malignant pancreatic neoplasmPhase 3
- Nasopharyngeal carcinomaPhase 3
- Pancreatic neoplasmPhase 3
- Thyroid cancerPhase 3
- Chronic kidney diseasePhase 2/3
- Colorectal cancerPhase 2/3
- EncephalopathyPhase 2
- Breast cancerPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL2106049, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Activated Charcoal
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Activated Charcoal
- ChEMBL
- CHEMBL2106049
- DrugBank
- DB09278
- PubChem CID
- 5462310
- CAS number
- 7440-44-0
- FDA UNII
- 4XYU5U00C4
- Wikidata
- Q866179
- Wikipedia
- Atomic carbon
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Activated Charcoal
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Activated CHARcoal in Poisoned Patient - Pilot Trial
NCT05471479 · ClinicalTrials.gov ↗ · Charcoal, Decontamination, Poisoning
|
Phase 4 | Recruiting | Laval University | Canada |
|
Activated Charcoal Use in Chronic Kidney Disease Patients
NCT06906874 · ClinicalTrials.gov ↗ · End Stage Renal Disease (ESRD), CKD 5D, Hemodialysis, CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
|
Phase 2 | Recruiting | Mansoura University | Egypt |
|
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
NCT06141473 · Multiple Sclerosis
|
Phase 3 | Active, closed | Sanofi | UK, USA, India, China, Germany, France, Spain, Italy, Belgium, Denmark, Poland, Switzerland, Austria, Czechia, Portugal, Turkey, Canada, Brazil, Mexico, Japan, South Korea, Taiwan, Singapore, Israel |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Activated Charcoal across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- Activated Charcoal Oral SuspensionUS (FDA) · Resolved · updated 15 May 2026
Conditions studied with Activated Charcoal
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Sanofi | 1 |
| Laval University | 1 |
| Mansoura University | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Activated Charcoal trials
How many clinical trials are testing Activated Charcoal?
3 current trials in our Canada, UK, USA, India, China, Germany, France, Spain, Italy, Belgium, Denmark, Poland, Switzerland, Austria, Czechia, Portugal, Turkey, Brazil, Mexico, Japan, South Korea, Taiwan, Singapore, Israel and Egypt registers name Activated Charcoal as a drug or biological intervention, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.
Are Activated Charcoal trials recruiting patients?
Yes. 2 of the 3 trials are recruiting: 1 with sites in Canada and 1 with sites in Egypt. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Activated Charcoal clinical trials?
Sanofi (1), Laval University (1) and Mansoura University (1). The number in brackets is how many trials each organisation leads.
Is there a Activated Charcoal shortage?
The registers we track list 1 entry for Activated Charcoal: US FDA: resolved. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Activated Charcoal works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Activated Charcoal works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Activated Charcoal (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.